<Database>
	<GameDBStringTable ID="LOC_FR_ADDON_CRP_SYMPTOMS">
	<LanguageCode>fr</LanguageCode>
	<LanguageNameLocalized>Français</LanguageNameLocalized>
	<Contributors>
	<Name>Nico57970</Name>
	<Name>MacNaab</Name>
	</Contributors>

	<LocalizedStrings>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ACTINIC_KERATOSIS</LocID>                               
		<Text>Kératose actinique</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ACTINIC_KERATOSIS_DESC</LocID>                   
		<Text>Une kératose actinique est une tache rugueuse et squameuse sur la peau qui se développe après des années d'exposition au soleil.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_NODULE_SKIN</LocID>                               
		<Text>Nodule sur la peau</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_NODULE_SKIN_DESC</LocID>                   
		<Text>Une petite bosse ou nodule sur la peau.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC1_1_DETECTED</LocID>                               
		<Text>Carcinome basocellulaire détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC1_1_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un carcinome basocellulaire sans signe de métastase.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC1_2_DETECTED</LocID>                               
		<Text>Carcinome basocellulaire détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC1_2_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un carcinome basocellulaire sans signe de métastase.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_PERINEURAL_INVASION</LocID>                               
		<Text>Invasion périneurale</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_PERINEURAL_INVASION_DESC</LocID>                   
		<Text>L'invasion périneurale se réfère à l'invasion du cancer dans l'espace entourant un nerf.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC1_3_DETECTED</LocID>                               
		<Text>Carcinome basocellulaire détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC1_3_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un carcinome basocellulaire avec des signes de propagation aux ganglions lymphatiques voisins et aux tissus environnants.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC1_4_DETECTED</LocID>                               
		<Text>Carcinome basocellulaire détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC1_4_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un carcinome basocellulaire avec des signes qu'il est métastatique.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_METASTASIZED_CANCER</LocID>                               
		<Text>Cancer métastatique</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_METASTASIZED_CANCER_DESC</LocID>                   
		<Text>Le cancer métastatique est un cancer qui se propage de sa zone d'origine vers une autre partie du corps.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CHRONIC_WOUND</LocID>                               
		<Text>Plaie chronique</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CHRONIC_WOUND_DESC</LocID>                   
		<Text>Les plaies chroniques sont des plaies qui ne sont toujours pas guéries après environ trois mois. Elles peuvent diminuer et se refermer légerement mais elles ne s’améliorent pas.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC2_1_DETECTED</LocID>                               
		<Text>Carcinome épidermoïde détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC2_1_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un carcinome épidermoïde sans aucun signe de métastase.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC2_2_DETECTED</LocID>                               
		<Text>Carcinome épidermoïde détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC2_2_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un carcinome épidermoïde sans aucun signe de métastase.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC2_3_DETECTED</LocID>                               
		<Text>Carcinome épidermoïde détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC2_3_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un carcinome épidermoïde avec des signes de propagation aux ganglions lymphatiques voisins et aux tissus environnants.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC2_4_DETECTED</LocID>                               
		<Text>Carcinome épidermoïde détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC2_4_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un carcinome épidermoïde avec des signes qu'il est métastatique.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ABNORMAL_MOLE</LocID>                               
		<Text>Grain de beauté anormale</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ABNORMAL_MOLE_DESC</LocID>                   
		<Text>Un grain de beauté avec une bordure inégale, une couleur inhabituelle ou une taille anormale.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC3_1_DETECTED</LocID>                               
		<Text>Mélanome détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC3_1_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un mélanome sans aucun signe de métastase.</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC3_2_DETECTED</LocID>                               
		<Text>Mélanome détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC3_2_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un mélanome sans aucun signe de métastase.</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC3_3_DETECTED</LocID>                               
		<Text>Mélanome détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC3_3_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un mélanome avec des signes de propagation aux ganglions lymphatiques voisins et aux tissus environnants.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC3_4_DETECTED</LocID>                               
		<Text>Mélanome détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC3_4_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un mélanome avec des signes qu'il est métastatique.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HIGH_EPLVL</LocID>                               
		<Text>Taux élevé d'épinéphrine</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HIGH_EPLVL_DESC</LocID>                   
		<Text>Le patient a des taux élevés d'épinéphrine(adrénaline) dans le sang. L'adrénaline est normalement produite par les glandes surrénales.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HIGH_NEPLVL</LocID>                               
		<Text>Taux élevé de norépinéphrine</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HIGH_NEPLVL_DESC</LocID>                   
		<Text>Le patient a des taux élevés de norépinéphrine(noradrénaline) dans le sang. La noradrénaline est un produit chimique naturel dans le corps qui agit à la fois comme une hormone du stress et comme un neurotransmetteur. Il est libéré dans le sang sous forme d'hormone de stress lorsque le cerveau perçoit qu'un événement stressant s'est produit. </Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_AGC1_0_DETECTED</LocID>                               
		<Text>Phéochromocytome détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_AGC1_0_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un phéochromocytome avec des preuves qu'il n'est que localisé.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_AGC1_1_DETECTED</LocID>                               
		<Text>Phéochromocytome détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_AGC1_1_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un phéochromocytome avec des preuves qu'il est régional.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_AGC1_2_DETECTED</LocID>                               
		<Text>Phéochromocytome détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_AGC1_2_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un phéochromocytome avec des preuves qu'il est métastatique.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_LC_0_DETECTED</LocID>                               
		<Text>Cancer du poumon non à petites cellules(CBNPC) détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_LC_0_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un cancer du poumon non à petites cellules avec des preuves qu'il n'est que localisé.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_LC_1_DETECTED</LocID>                               
		<Text>Cancer du poumon non à petites cellules(CBNPC) détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_LC_1_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un cancer du poumon non à petites cellules avec des preuves qu'il est régional.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_SL_SEIZURES</LocID>                               
		<Text>Crise convulsives</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_SL_SEIZURES_DESC</LocID>                   
		<Text>Une crise convulsives est une perturbation électrique soudaine et incontrôlée du cerveau. Cela peut entraîner des changements dans le comportement, les mouvements, les sentiments et dans les niveaux de conscience.</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_LC_2_DETECTED</LocID>                               
		<Text>Cancer du poumon non à petites cellules(CBNPC) détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_LC_2_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un cancer du poumon non à petites cellules avec des preuves qu'il est métastatique</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_SL_HEMOPTYSIS1</LocID>                               
		<Text>Hémoptysie légère</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_SL_HEMOPTYSIS1_DESC</LocID>                   
		<Text>L'hémoptysie est la toux accompagnée de sang ou de mucus taché de sang venues des bronches, du larynx, de la trachée ou des poumons. En d'autres termes, c'est le saignement des voies respiratoires. Cela peut se produire avec le cancer du poumon, des infections telles que la tuberculose, la bronchite, la pneumonie ou certaines conditions cardiovasculaires.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_LC1_0_DETECTED</LocID>                               
		<Text>Cancer du poumon à petites cellules(CBPC) détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_LC1_0_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté le cancer du poumon à petites cellules avec des preuves qu'il est à un stade restreint.</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_LC1_1_DETECTED</LocID>                               
		<Text>Cancer du poumon à petites cellules(CBPC) détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_LC1_1_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté le cancer du poumon à petites cellules avec des preuves qu'il est à un stade étendu.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_NERVE_DAMAGE</LocID>                               
		<Text>Douleur neuropathique post-opératoire</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_NERVE_DAMAGE_DESC</LocID>                   
		<Text>Une douleur neuropathique postopératoire peut se développer si les nerfs ont été endommagés lors d'une intervention chirurgicale. Les nerfs endommagés ne peuvent pas transmettre correctement les signaux des diverses parties du corps vers le cerveau. Au lieu de cela, ces signaux deviennent exagérés, provoquant une douleur chronique qui peut persister pendant des mois, voire des années.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BC1_0_DETECTED</LocID>                               
		<Text>Adénocarcinome colorectal détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BC1_0_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un adénocarcinome colorectal avec des preuves qu'il n'est que localisé.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BC1_1_DETECTED</LocID>                               
		<Text>Adénocarcinome colorectal détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BC1_1_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un adénocarcinome colorectal avec des preuves qu'il est régional.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BC1_2_DETECTED</LocID>                               
		<Text>Adénocarcinome colorectal détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BC1_2_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un adénocarcinome colorectal avec des preuves qu'il est métastatique</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HIGH_CEALVL</LocID>                               
		<Text>Taux élevé d'antigène carcinoembryonnaire</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HIGH_CEALVL_DESC</LocID>                   
		<Text>Le patient présente des taux élevés d'antigène carcinoembryonnaire dans le sang. Un niveau élevé d'ACE peut être le signe de certains types de cancers. Il s'agit notamment des cancers du colon, du rectum, de la prostate, des ovaires, des poumons, de la thyroïde ou du foie. Des taux élevés d'ACE peuvent également être le signe de certaines affections non cancéreuses, telles que la cirrhose, la maladie mammaire non cancéreuse et l'emphysème.</Text> 
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_POLYPS</LocID>                               
		<Text>Polype colorectal</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_POLYPS_DESC</LocID>                   
		<Text>Un polype est une croissance de tissu sur la muqueuse du colon et du rectum qui se projette dans les intestins. Les personnes atteintes de polypes du colon ne présentent généralement aucun symptôme. La plupart des polypes du colon sont inoffensifs, mais certains types peuvent devenir cancéreux.</Text> 
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_AGC2_0_DETECTED</LocID>                               
		<Text>Carcinome corticosurrénal détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_AGC2_0_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un carcinome corticosurrénal avec des preuves qu'il n'est que localisé.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_AGC2_1_DETECTED</LocID>                               
		<Text>Carcinome corticosurrénal détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_AGC2_1_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un carcinome corticosurrénal avec des preuves qu'il est régional.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_AGC2_2_DETECTED</LocID>                               
		<Text>Carcinome corticosurrénal détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_AGC2_2_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté un carcinome corticosurrénal avec des preuves qu'il est métastatique.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HYPONATREMIA</LocID>                               
		<Text>Hyponatrémie</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HYPONATREMIA_DESC</LocID>                   
		<Text>L'hyponatrémie survient lorsque la concentration de sodium dans votre sang est anormalement basse. Le sodium est un électrolyte et il aide à réguler la quantité d'eau dans et autour de vos cellules.</Text> 
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HYPERGLYCEMIA</LocID>                               
		<Text>Hyperglycémie</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HYPERGLYCEMIA_DESC</LocID>                   
		<Text>L'hyperglycémie est le terme technique pour désigner un taux de sucre dans le sang élevé. Une glycémie élevée survient lorsque le corps a trop peu d'insuline ou lorsque le corps ne peut pas utiliser l'insuline correctement.</Text> 
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HYPERCORTISOL</LocID>                               
		<Text>Hypercortisolisme</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HYPERCORTISOL_DESC</LocID>                   
		<Text>Le syndrome de Cushing, également appelé hypercortisolisme, est un trouble endocrinien rare causé par une exposition chronique des tissus de l'organisme à des niveaux excessifs de cortisol - une hormone produite naturellement par la glande surrénale.</Text> 
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HYPERALDOSTERONISM</LocID>                               
		<Text>Hyperaldostéronisme</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HYPERALDOSTERONISM_DESC</LocID>                   
		<Text>L'hyperaldostéronisme est une maladie dans laquelle les glandes surrénales produisent trop d'aldostérone, ce qui entraîne une hypertension et de faibles taux de potassium dans le sang. L'hyperaldostéronisme primaire peut être causé par une hyperactivité dans une glande surrénale(maladie unilatérale) ou les deux(maladie bilatérale).</Text> 
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_MC001_0_DETECTED</LocID>                               
		<Text>TNE gastro-intestinal détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_MC001_0_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une tumeur neuroendocrine(TNE) gastro-intestinale avec des preuves qu'elle est à un stade restreint.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_MC001_1_DETECTED</LocID>                               
		<Text>TNE gastro-intestinal détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_MC001_1_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une tumeur neuroendocrine(TNE) gastro-intestinale avec des preuves qu'elle est à un stade étendu.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_LARGE_LYMPHNODE</LocID>                               
		<Text>Lymphadénite</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_LARGE_LYMPHNODE_DESC</LocID>                   
		<Text>La lymphadénite est lorsque les ganglions lymphatiques enflent en réponse à une maladie, une infection ou un stress. Les ganglions lymphatiques enflés sont un signe que votre système lymphatique travaille pour débarrasser votre corps des agents responsables. Les glandes du système immunitaire grossissent généralement en réponse à une infection bactérienne ou virale, mais un gonflement soudain de nombreux ganglions lymphatiques peut indiquer un cancer.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ELAVATED_5HIAA</LocID>                               
		<Text>Taux élevé de 5-HIAA</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ELAVATED_5HIAA_DESC</LocID>                   
		<Text>Le patient a des taux élevés de 5-HIAA(acide 5-hydroxyindol-acétique) dans ses urines. Sérotonine, mesurée dans l'urine sous acide 5 hydroxyindolacétique(5HIAA). Des niveaux élevés de 5-HIAA sont corrélés avec le syndrome carcinoïde et les crises carcinoïdes. Une exposition prolongée des valves cardiaques à des niveaux élevés de sérotonine est associée à des complications de la maladie.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CGA_BL_DETECTED</LocID>                               
		<Text>Taux élevé de chromogranine-A</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CGA_BL_DETECTED_DESC</LocID>                   
		<Text>Le patient a des taux élevés de marqueur tumoral Chromogranine-A dans son sang. La chromogranine A (CHGA) est un marqueur associé à toutes les tumeurs carcinoïdes. C'est une protéine produite et libérée par les cellules tumorales. La CHGA est associée à d'autres hormones et peut jouées sur leur régulation.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CARCINOID_CRISIS</LocID>                               
		<Text>Crise carcinoïde</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CARCINOID_CRISIS_DESC</LocID>                   
		<Text>La crise carcinoïde est une forme potentiellement mortelle de syndrome carcinoïde qui résulte de la libération d'une quantité excessives de composés biologique de la tumeur et qui peut être déclenchée par un stress extrême, une manipulation tumorale(biopsie ou chirurgie) ou par une anesthésie.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ANAPHYLACTIC_SHOCK</LocID>                               
		<Text>Choc anaphylactique</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ANAPHYLACTIC_SHOCK_DESC</LocID>                   
		<Text>Le choc anaphylactique est une réaction allergique rare mais grave qui peut être mortelle si vous ne la traitez pas tout de suite. Elle est le plus souvent causée par une allergie à la nourriture, aux piqûres d'insectes ou à certains médicaments. Une injection d'un médicament appelé adrénaline est nécessaire immédiatement.</Text>  
	</GameDBLocalizedString>
	
	<!-- Blood Cancer Symptoms -->
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_UNUSUAL_INFECT</LocID>                               
		<Text>Infection inhabituelle</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_UNUSUAL_INFECT_DESC</LocID>                   
		<Text>Une infection dont la cause est inconnue ou qui présente des propriétés inhabituelles.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_FREQUENT_INFECT</LocID>                               
		<Text>Infections fréquentes</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_FREQUENT_INFECT_DESC</LocID>                   
		<Text>Les infections fréquentes sont des infections trop nombreuses, trop graves ou de trop longue durée. Des infections fréquentes ou récurrentes peuvent survenir parce que le corps ne produit pas suffisamment de globules blancs pour que le système immunitaire fonctionne correctement.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_LYMPHOCYTOSIS</LocID>                               
		<Text>Lymphocytose</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_LYMPHOCYTOSIS_DESC</LocID>                   
		<Text>La lymphocytose est une quantité supérieure à la normale de lymphocytes, un sous-type de globules blancs, dans le corps. Les lymphocytes font partie de votre système immunitaire et luttent contre les infections.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_PETECHIAE</LocID>                               
		<Text>Pétéchie</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_PETECHIAE_DESC</LocID>                   
		<Text>Les pétéchies sont des petites taches cutanée de couleur rouge à violacées qui apparaissent sur la peau ou dans une membrane muqueuse. Ils surviennent à la suite de saignements sous la peau.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BLEEDING_GUM</LocID>                               
		<Text>Saignement des gencives</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BLEEDING_GUM_DESC</LocID>                   
		<Text>Le saignement des gencives est le symptôme le plus courant de maladie des gencives. Mais cela peut également signaler d'autres problèmes de santé. Des saignements occasionnels des gencives peuvent être causés par un brossage trop vigoureux des dents ou le port de prothèses dentaires qui ne s’adaptent pas correctement. Des saignements fréquents des gencives peuvent également indiquer des problèmes plus graves.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HIGH_TCOUNT</LocID>                               
		<Text>Nombre élevé de Lymphocytes T</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HIGH_TCOUNT_DESC</LocID>                   
		<Text>Un nombre élevé de lymphocytes T peut être dû à: la mononucléose infectieuse, également connue sous le nom de mono ou «la maladie du baiser», la leucémie lymphoïde aiguë (LAL), un type de cancer qui affecte les globules blancs.le myélome multiple, un type de cancer qui affecte les plasmocytes de la moelle osseuse.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_RC_APLASIA</LocID>                               
		<Text>Aplasie des globules rouges</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_RC_APLASIA_DESC</LocID>                   
		<Text>L'aplasie pure des globules rouges ou l'érythroblastopénie fait référence à un type d'anémie affectant les précurseurs des globules rouges mais pas des globules blancs.La moelle osseuse cesse de produire des globules rouges. Il existe plusieurs étiologies qui peuvent provoquer l'aplasie des globules rouges.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CHRONIC_NEUT</LocID>                               
		<Text>Neutropénie</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CHRONIC_NEUT_DESC</LocID>                   
		<Text>La neutropénie correspond un faible niveau de neutrophiles. Les neutrophiles sont un type de globule blanc. Tous les globules blancs aident le corps à combattre l'infection. Les neutrophiles combattent l'infection en détruisant les bactéries et les champignons nuisibles qui envahissent le corps. Les neutrophiles sont fabriqués dans la moelle osseuse.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SPLENOMEGALY</LocID>                               
		<Text>Splénomégalie</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SPLENOMEGALY_DESC</LocID>                   
		<Text>La splénomégalie est une affection qui survient lorsque votre rate grossit. Il est également communément appelé hypertrophie de la rate.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_RUP_SPLENOMEGALY</LocID>                               
		<Text>Rupture de la rate</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_RUP_SPLENOMEGALY_DESC</LocID>                   
		<Text>Une rupture de rate est une urgence médicale qui survient lorsque le revêtement, en forme de capsule, de la rate s'ouvre versant du sang dans votre abdomen. Selon la taille de la rupture, une importante hémorragie interne peut survenir.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HEPATOMEGALY</LocID>                               
		<Text>Hépatomégalie</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HEPATOMEGALY_DESC</LocID>                   
		<Text>L'hépatomégalie se produit lorsque le foie est anormalement gros. C'est souvent le signe d'un grave problème de santé.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_THROMBOCYTOPENIA</LocID>                               
		<Text>Thrombocytopénie</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_THROMBOCYTOPENIA_DESC</LocID>                   
		<Text>La thrombocytopénie est une affectation dans laquelle votre taux de plaquettes dans le sang est bas. Les plaquettes(thrombocytes) sont des cellules sanguines incolores qui aident à la coagulation sanguine. Les plaquettes arrêtent le saignement en s'agglomérant et en formant des bouchons dans les lésions des vaisseaux sanguins.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_02</LocID>                               
		<Text>Défaut gène PML-RARA détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_02_DESC</LocID>                   
		<Text>Les cellules LAP(leucémie aiguë promyélocytaire) ont une anomalie très spécifique appelée «translocation équilibrée», dans laquelle des parties des chromosomes 15 et 17 sont permutées. Il en résulte la formation d'un gène de fusion anormal appelé «PML/RARα». Ce gène muté provoque de nombreuses caractéristiques de la maladie.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_FISH_POSLESION</LocID>                               
		<Text>Lésion FISH Positive</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_FISH_POSLESION_DESC</LocID>                   
		<Text>La lésion du patient a été testée et les examens FISH ont confirmé qu'elle était cancéreuses.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_01</LocID>                               
		<Text>Défaut chromosome de philadelphie détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_01_DESC</LocID>                   
		<Text>Le chromosome de Philadelphie ou translocation de Philadelphie(Ph) est une anomalie génétique spécifique du chromosome 22 des cellules cancéreuses de la leucémie (en particulier les cellules de la leucémie myéloïde chronique (LMC)). Le défaut chromosomique du chromosome de Philadelphie est une translocation réciproque, dans laquelle des parties de deux chromosomes, 9 et 22, changent de place. La présence de cette translocation est un examen très sure pour la LMC, car la plupart des cas de LMC sont positifs.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SM_P_001</LocID>                               
		<Text>Myéloperoxydase (MPO) positive</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SM_P_001_DESC</LocID>                   
		<Text>La myéloperoxydase est une enzyme lysosomale, située dans les granules azurophiles des neutrophiles et ses précurseurs, les éosinophiles et les monocytes. Cette coloration est principalement utilisée pour différencier la leucémie myéloïde aiguë de la leucémie lymphoblastique aiguë.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SM_P_002</LocID>                               
		<Text>Test Soudan Noir B Positif</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SM_P_002_DESC</LocID>                   
		<Text>Le Soudan Noir B est un colorant azoïque. Il s'agit d'un colorant diazo lysochrome(colorant liposoluble) non fluorescent et relativement thermostable utilisé pour la coloration des triglycérides et lipides neutres. Dans la différenciation des troubles hématologiques, il colorera les myéloblastes mais pas les lymphoblastes.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_03</LocID>                               
		<Text>Mutation IDH1 / IDH2 détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_03_DESC</LocID>                   
		<Text>L'isocitrate déshydrogénase (IDH) est une enzyme clé impliquée dans la conversion de l'isocitrate en α-cétoglutarate(α-KG) dans le cycle de l'acide tricarboxylique. La mutation IDH produit une enzyme néomorphe, ce qui peut entraîner une accumulation anormale de R-2-HG et favoriser la leucémogenèse. La mutation IDH survient chez 20% des patients atteints de leucémie myéloïde aiguë (LMA), notamment IDH1 R132, IDH2 R140 et IDH2 R172.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_04</LocID>                               
		<Text>Fusion gène BCR-ABL Détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_04_DESC</LocID>                   
		<Text>BCR-ABL est une mutation formée par la fusion de deux gènes, appelés BCR et ABL. Le gène BCR est normalement sur le chromosome numéro 22. Le gène ABL est normalement sur le chromosome numéro 9. La mutation BCR-ABL se produit lorsque des morceaux de gènes BCR et ABL se détachent et changent de place.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_05</LocID>                               
		<Text>Gène de la trisomie 8 détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_05_DESC</LocID>                   
		<Text>La trisomie 8, également connue sous le nom de syndrome de Warkany 2, est une maladie chromosomique humaine causée par la présence de trois copies(trisomie) du chromosome 8. Elle peut apparaître avec ou sans mosaïque. Le terme «mosaïque» indique que certaines cellules contiennent le chromosome supplémentaire tandis que d'autres n'en contiennent pas.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_06</LocID>                               
		<Text>Gène de la trisomie 9 détecté</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_06_DESC</LocID>                   
		<Text>La trisomie 9 en mosaïque est une maladie chromosomique rare dans laquelle le 9e chromosome entier apparaît trois fois(trisomie) plutôt que deux fois dans certaines cellules du corps. Le terme "mosaïque" indique que certaines cellules contiennent le chromosome 9 supplémentaire, tandis que d'autres ont la paire chromosomique normale.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_07</LocID>                               
		<Text>Duplication du Chromosome de Philadelphie</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_07_DESC</LocID>                   
		<Text>Une duplication défectueuse d'un chromosome, le chromosome de Philadelphie, a été détectée. Cela peut se produire à des stades plus avancés de la leucémie myéloïde chronique.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BLA_HIGH1</LocID>                               
		<Text>Taux de blastes élevé</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BLA_HIGH1_DESC</LocID>                   
		<Text>Les blastes sont cellules sanguines immatures en circulation telles que les neutrophiles, les monocytes, les lymphocytes et les érythrocytes. Les blastes se trouvent généralement en nombre dans la moelle osseuse. On ne les trouve généralement pas en grand nombre dans le sang. Les examens ont détecté un niveau élevé de blastes dans le sang des patients(entre 5 et 19%).</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BLA_HIGH2</LocID>                               
		<Text>Taux de blastes très élevé</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BLA_HIGH2_DESC</LocID>                   
		<Text>Les blastes sont cellules sanguines immatures en circulation telles que les neutrophiles, les monocytes, les lymphocytes et les érythrocytes. Les blastes se trouvent généralement en nombre dans la moelle osseuse. On ne les trouve généralement pas en grand nombre dans le sang. Les examens ont détecté un niveau très élevé de blastes dans le sang des patients(plus de 20%).</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BLA_HIGH3</LocID>                               
		<Text>Taux de blastes hyper élevé</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BLA_HIGH3_DESC</LocID>                   
		<Text>Les blastes sont cellules sanguines immatures en circulation telles que les neutrophiles, les monocytes, les lymphocytes et les érythrocytes. Les blastes se trouvent généralement en nombre dans la moelle osseuse. On ne les trouve généralement pas en grand nombre dans le sang. Les examens ont détecté un niveau hyper élevé de blastes dans le sang des patients (supérieur à 30%). À ce niveau, les cellules blastiques évincent les globules blancs normaux, ce qui les rend beaucoup moins efficaces.</Text>  
	</GameDBLocalizedString>
	
	<!-- leukaemia -->
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC01_0_DETECTED</LocID>                               
		<Text>Leucémie aiguë lymphoblastique pré-B détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC01_0_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une leucémie lymphoblastique de type pré-B avec des preuves qu'elle est aiguë.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC01_1_DETECTED</LocID>                               
		<Text>Leucémie aiguë lymphoblastique B détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC01_1_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une leucémie lymphoblastique de type B avec des preuves qu'elle est aiguë.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC02_A_DETECTED</LocID>                               
		<Text>Leucémie lymphoïde chronique détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC02_A_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une leucémie lymphocytaire avec des preuves qu'elle est chronique mais stable.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC02_B_DETECTED</LocID>                               
		<Text>Leucémie lymphoïde chronique détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC02_B_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une leucémie lymphocytaire avec des preuves qu'elle est chronique et dans un état avancé.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC01_2_DETECTED</LocID>                               
		<Text>Leucémie aiguë lymphoblastique T détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC01_2_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une leucémie lymphoblastique de type T avec des preuves qu'elle est aiguë.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC01_3_DETECTED</LocID>                               
		<Text>Leucémie aiguë lymphoblastique T détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC01_3_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une leucémie lymphoblastique de type T avec des preuves qu'elle est aiguë.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC03_0_DETECTED</LocID>                               
		<Text>Leucémie à grands lymphocytes granuleux T détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC03_0_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une leucémie lymphocytaire avec des preuves qu'il s'agit d'un sous-type, la leucémie à grands lymphocytes granuleux T(GLG-T).</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC03_1_DETECTED</LocID>                               
		<Text>Leucémie à grands lymphocytes granuleux NK détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC03_1_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une leucémie lymphocytaire avec des preuves qu'il s'agit d'un sous-type, la leucémie à grands lymphocytes granuleux NK(GLG-NK).</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC03_2_DETECTED</LocID>                               
		<Text>Leucémie prolymphocytaire à cellules T détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC03_2_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une leucémie lymphocytaire avec des preuves qu'il s'agit d'un sous-type rare, la leucémie prolymphocytaire à cellules T (LPL-T).</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC04_0_DETECTED</LocID>                               
		<Text>Leucémie myéloïde aiguë (LMA) détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC04_0_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une leucémie myéloïde avec des preuves qu'elle est aiguë.</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC05_A_DETECTED</LocID>                               
		<Text>Leucémie myéloïde chronique (LMC) détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC05_A_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une leucémie myéloïde avec des preuves qu'elle est dans sa phase chronique.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC05_B_DETECTED</LocID>                               
		<Text>Leucémie myéloïde chronique (LMC) détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC05_B_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une leucémie myéloïde avec des preuves qu'elle est dans sa phase accelérée.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC05_C_DETECTED</LocID>                               
		<Text>Leucémie myéloïde chronique (LMC) détectée</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC05_C_DETECTED_DESC</LocID>                   
		<Text>Les examens ont détecté une leucémie myéloïde avec des preuves qu'elle est dans sa phase blastique.</Text>  
	</GameDBLocalizedString>

	<!-- ############### CELL MARKERS ############### -->
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD10_BRIGHT</LocID>                               
		<Text>Neprilysin (CD10) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD10_BRIGHT_DESC</LocID>                   
		<Text>Neprilysin, also known as membrane metallo-endopeptidase, neutral endopeptidase, cluster of differentiation 10, and common acute lymphoblastic leukemia antigen is an enzyme that in humans is encoded by the MME gene. Identified in common acute lymphoblastic leukemia as a cancer specific antigen, CD10 is a cell surface ectoenzyme widely expressed on different types of cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD10_NEG</LocID>                               
		<Text>Neprilysin (CD10) Negative Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD10_NEG_DESC</LocID>                   
		<Text>Neprilysin, also known as membrane metallo-endopeptidase, neutral endopeptidase, cluster of differentiation 10, and common acute lymphoblastic leukemia antigen is an enzyme that in humans is encoded by the MME gene. Identified in common acute lymphoblastic leukemia as a cancer specific antigen, CD10 is a cell surface ectoenzyme widely expressed on different types of cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD19_BRIGHT</LocID>                               
		<Text>CD19 Antigen Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD19_BRIGHT_DESC</LocID>                   
		<Text>B-lymphocyte antigen CD19, also known as CD19 molecule, B-Lymphocyte Surface Antigen B4, T-Cell Surface Antigen Leu-12 and CVID3 is a transmembrane protein that in humans is encoded by the gene CD19. In humans, CD19 is expressed in all B lineage cells, except for plasma cells, and in follicular dendritic cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD19_NEG</LocID>                               
		<Text>CD19 Antigen Negative Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD19_NEG_DESC</LocID>                   
		<Text>B-lymphocyte antigen CD19, also known as CD19 molecule, B-Lymphocyte Surface Antigen B4, T-Cell Surface Antigen Leu-12 and CVID3 is a transmembrane protein that in humans is encoded by the gene CD19. In humans, CD19 is expressed in all B lineage cells, except for plasma cells, and in follicular dendritic cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD20_DIM</LocID>                               
		<Text>CD20 Antigen Dim Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD20_DIM_DESC</LocID>                   
		<Text>B-lymphocyte antigen CD20 or CD20 is expressed on the surface of all B-cells beginning at the pro-B phase and progressively increasing in concentration until maturity. CD20 is a membrane-embedded surface molecule which plays a role in the development and differentiation of B-cells into plasma cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD20_BRIGHT</LocID>                               
		<Text>CD20 Antigen Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD20_BRIGHT_DESC</LocID>                   
		<Text>B-lymphocyte antigen CD20 or CD20 is expressed on the surface of all B-cells beginning at the pro-B phase and progressively increasing in concentration until maturity. CD20 is a membrane-embedded surface molecule which plays a role in the development and differentiation of B-cells into plasma cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_TDT_BRIGHT</LocID>                               
		<Text>TdT Antigen Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_TDT_BRIGHT_DESC</LocID>                   
		<Text>Terminal deoxynucleotidyl transferase (TdT), also known as DNA nucleotidylexotransferase (DNTT) or terminal transferase, is a specialized DNA polymerase expressed in immature, pre-B, pre-T lymphoid cells, and acute lymphoblastic leukemia/lymphoma cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_TDT_NEG</LocID>                               
		<Text>TdT Antigen Negative Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_TDT_NEG_DESC</LocID>                   
		<Text>Terminal deoxynucleotidyl transferase (TdT), also known as DNA nucleotidylexotransferase (DNTT) or terminal transferase, is a specialized DNA polymerase expressed in immature, pre-B, pre-T lymphoid cells, and acute lymphoblastic leukemia/lymphoma cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD22_DIM</LocID>                               
		<Text>CD22 Antigen Dim Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD22_DIM_DESC</LocID>                   
		<Text>CD22, or cluster of differentiation-22, is a molecule belonging to the SIGLEC family of lectins. It is found on the surface of mature B cells and to a lesser extent on some immature B cells. CD22 is a sugar binding transmembrane protein, which specifically binds sialic acid with an immunoglobulin (Ig) domain located at its N-terminus. The presence of Ig domains makes CD22 a member of the immunoglobulin superfamily. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signaling.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD22_BRIGHT</LocID>                               
		<Text>CD22 Antigen Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD22_BRIGHT_DESC</LocID>                   
		<Text>CD22, or cluster of differentiation-22, is a molecule belonging to the SIGLEC family of lectins. It is found on the surface of mature B cells and to a lesser extent on some immature B cells. CD22 is a sugar binding transmembrane protein, which specifically binds sialic acid with an immunoglobulin (Ig) domain located at its N-terminus. The presence of Ig domains makes CD22 a member of the immunoglobulin superfamily. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signaling.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD23_BRIGHT</LocID>                               
		<Text>Fc epsilon RII (CD23) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD23_BRIGHT_DESC</LocID>                   
		<Text>CD23, also known as Fc epsilon RII, or FcεRII, is the "low-affinity" receptor for IgE, an antibody isotype involved in allergy and resistance to parasites, and is important in regulation of IgE levels. Unlike many of the antibody receptors, CD23 is a C-type lectin. CD23 antigen is a cell surface protein considered important in the differentiation of chronic lymphocytic leukemia.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD34_BRIGHT</LocID>                               
		<Text>CD34 Antigen Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD34_BRIGHT_DESC</LocID>                   
		<Text>The CD34 protein is a member of a family of single-pass transmembrane sialomucin proteins that show expression on early hematopoietic and vascular-associated tissue. CD34 is also an important adhesion molecule and is required for T cells to enter lymph nodes. It is expressed on lymph node endothelia, whereas the L-selectin to which it binds is on the T cell.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD79a_BRIGHT</LocID>                               
		<Text>CD79a Antigen Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD79a_BRIGHT_DESC</LocID>                   
		<Text>Cluster of differentiation CD79A also known as B-cell antigen receptor complex-associated protein alpha chain and MB-1 membrane glycoprotein, is a protein that in humans is encoded by the CD79A gene. CD79a plays multiple and diverse roles in B cell development and function. The CD79a/b heterodimer associates non-covalently with the immunoglobulin heavy chain through its transmembrane region, thus forming the BCR along with the immunoglobulin light chain and the pre-BCR when associated with the surrogate light chain in developing B cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD79b_NEG</LocID>                               
		<Text>CD79b Antigen Negative Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD79b_NEG_DESC</LocID>                   
		<Text>CD79b molecule, immunoglobulin-associated beta, also known as CD79B (Cluster of Differentiation 79B), is a human gene. The CD79a/b heterodimer associates non-covalently with the immunoglobulin heavy chain through its transmembrane region, thus forming the BCR along with the immunoglobulin light chain and the pre-BCR when associated with the surrogate light chain in developing B cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD11c_BRIGHT</LocID>                               
		<Text>Integrin alpha X (CD11c) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD11c_BRIGHT_DESC</LocID>                   
		<Text>CD11c, also known as Integrin, alpha X (complement component 3 receptor 4 subunit) (ITGAX), is a gene that encodes for CD11c. CD11c is a type I transmembrane protein that is expressed on monocytes, granulocytes, a subset of B cells, dendritic cells, and macrophages and may be demonstrated on B-cell chronic lymphocytic leukemia, marginal zone lymphomas, and hairy cell leukemia.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD25_BRIGHT</LocID>                               
		<Text>IL2RA (CD25) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD25_BRIGHT_DESC</LocID>                   
		<Text>Interleukin-2 receptor alpha chain (also called CD25) is a protein that in humans is encoded by the IL2RA gene. The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. IL2RA is expressed in most B-cell neoplasms, some acute nonlymphocytic leukemias, neuroblastomas, mastocytosis and tumor infiltrating lymphocytes. It functions as the receptor for HTLV-1 and is consequently expressed on neoplastic cells in adult T cell lymphoma/leukemia.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD25_NEG</LocID>                               
		<Text>IL2RA (CD25) Negative Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD25_NEG_DESC</LocID>                   
		<Text>Interleukin-2 receptor alpha chain (also called CD25) is a protein that in humans is encoded by the IL2RA gene. The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. IL2RA is expressed in most B-cell neoplasms, some acute nonlymphocytic leukemias, neuroblastomas, mastocytosis and tumor infiltrating lymphocytes. It functions as the receptor for HTLV-1 and is consequently expressed on neoplastic cells in adult T cell lymphoma/leukemia.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD103_BRIGHT</LocID>                               
		<Text>ITGAE (CD103) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD103_BRIGHT_DESC</LocID>                   
		<Text>Integrin, alpha E also known as CD103 is an integrin protein that in human is encoded by the ITGAE gene. CD103 is expressed widely on intraepithelial lymphocyte (IEL) T cells (both αβ T cells and γδ T cells) and on some peripheral regulatory T cells (Tregs). It is useful in identifying hairy cell leukemia which is positive for this marker in contrast to most other hematologic malignancies which are negative for CD103 except enteropathy-associated T cell lymphoma.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD123_DIM</LocID>                               
		<Text>Interleukin-3 Receptor (CD123) Dim Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD123_DIM_DESC</LocID>                   
		<Text>The interleukin-3 receptor (CD123) is a molecule found on cells which helps transmit the signal of interleukin-3, a soluble cytokine important in the immune system. The receptor, found on pluripotent progenitor cells, induces tyrosine phosphorylation within the cell and promotes proliferation and differentiation within the hematopoietic cell lines. CD123 is expressed across acute myeloid leukemia (AML) subtypes, including leukemic stem cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD123_BRIGHT</LocID>                               
		<Text>Interleukin-3 Receptor (CD123) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD123_BRIGHT_DESC</LocID>                   
		<Text>The interleukin-3 receptor (CD123) is a molecule found on cells which helps transmit the signal of interleukin-3, a soluble cytokine important in the immune system. The receptor, found on pluripotent progenitor cells, induces tyrosine phosphorylation within the cell and promotes proliferation and differentiation within the hematopoietic cell lines. CD123 is expressed across acute myeloid leukemia (AML) subtypes, including leukemic stem cells.</Text>  
	</GameDBLocalizedString>
	
		<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD123_NEG</LocID>                               
		<Text>Interleukin-3 Receptor (CD123) Negative Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD123_NEG_DESC</LocID>                   
		<Text>The interleukin-3 receptor (CD123) is a molecule found on cells which helps transmit the signal of interleukin-3, a soluble cytokine important in the immune system. The receptor, found on pluripotent progenitor cells, induces tyrosine phosphorylation within the cell and promotes proliferation and differentiation within the hematopoietic cell lines. CD123 is expressed across acute myeloid leukemia (AML) subtypes, including leukemic stem cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD1a_BRIGHT</LocID>                               
		<Text>CD1a Antigen Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD1a_BRIGHT_DESC</LocID>                   
		<Text>CD1a (Cluster of Differentiation 1a) is a human protein encoded by the CD1A gene. This gene encodes a member of the CD1 family of transmembrane glycoproteins, which are structurally related to the major histocompatibility complex (MHC) proteins and form heterodimers with beta-2-microglobulin. The CD1 proteins mediate the presentation of primarily lipid and glycolipid antigens of self or microbial origin to T cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD1a_NEG</LocID>                               
		<Text>CD1a Antigen Negative Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD1a_NEG_DESC</LocID>                   
		<Text>CD1a (Cluster of Differentiation 1a) is a human protein encoded by the CD1A gene. This gene encodes a member of the CD1 family of transmembrane glycoproteins, which are structurally related to the major histocompatibility complex (MHC) proteins and form heterodimers with beta-2-microglobulin. The CD1 proteins mediate the presentation of primarily lipid and glycolipid antigens of self or microbial origin to T cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD5_BRIGHT</LocID>                               
		<Text>CD5 Antigen Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD5_BRIGHT_DESC</LocID>                   
		<Text>CD5 is a cluster of differentiation expressed on the surface of T cells (various species) and in a subset of murine B cells known as B-1a. The expression of this receptor in human B cells has been a controversial topic and up to date there is no consensus regarding the role of this receptor as a marker of human B cells. CD5 is a good immunohistochemical marker for T-cells, although not as sensitive as CD3. About 76% of T-cell neoplasms are reported to express CD5, and it is also found in chronic lymphocytic leukemia and mantle cell lymphoma (both being B cell malignancies), that do not express CD3. It is commonly lost in cutaneous T-cell lymphoma, and its absence can be used as an indicator of malignancy in this condition.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD7_BRIGHT</LocID>                               
		<Text>CD7 Antigen Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD7_BRIGHT_DESC</LocID>                   
		<Text>CD7 (Cluster of Differentiation 7) is a protein that in humans is encoded by the CD7 gene. This gene encodes a transmembrane protein which is a member of the immunoglobulin superfamily. This protein is found on thymocytes and mature T cells. It plays an essential role in T-cell interactions and also in T-cell/B-cell interaction during early lymphoid development. This gene encodes a transmembrane protein which is a member of the immunoglobulin superfamily. This protein is found on thymocytes and mature T cells. It plays an essential role in T-cell interactions and also in T-cell/B-cell interaction during early lymphoid development.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD13_BRIGHT</LocID>                               
		<Text>Aminopeptidase N (CD13) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD13_BRIGHT_DESC</LocID>                   
		<Text>Membrane alanyl aminopeptidase (EC 3.4.11.2) also known as alanyl aminopeptidase (AAP) or aminopeptidase N (AP-N) is an enzyme that in humans is encoded by the ANPEP gene. Aminopeptidase N is located in the small-intestinal and renal microvillar membrane, and also in other plasma membranes. In the small intestine aminopeptidase N plays a role in the final digestion of peptides generated from hydrolysis of proteins by gastric and pancreatic proteases. Its function in proximal tubular epithelial cells and other cell types is less clear. Defects in this gene appear to be a cause of various types of leukemia or lymphoma.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD15_BRIGHT</LocID>                               
		<Text>Sialyl-Lewis X (CD15) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD15_BRIGHT_DESC</LocID>                   
		<Text>Sialyl LewisX (sLeX) also known as cluster of differentiation 15s (CD15s) or stage-specific embryonic antigen 1 (SSEA-1), is a tetrasaccharide carbohydrate which is usually attached to O-glycans on the surface of cells. It is known to play a vital role in cell-to-cell recognition processes. It is also the means by which an egg attracts sperm; first, to stick to it, then bond with it and eventually form a zygote. Sialyl-Lewisx mediates phagocytosis and chemotaxis, found on neutrophils; expressed in patients with Hodgkin disease, some B-cell chronic lymphocytic leukemias, acute lymphoblastic leukemias, and most acute nonlymphocytic leukemias. CD15 is present on almost all Reed–Sternberg cells, including their rare mononuclear variants, and, as such, can be used in immunohistochemistry to identify the presence of such cells in biopsies.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD33_BRIGHT</LocID>                               
		<Text>Siglec-3 (CD33) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD33_BRIGHT_DESC</LocID>                   
		<Text>CD33 or Siglec-3 (sialic acid binding Ig-like lectin 3, SIGLEC3, SIGLEC-3, gp67, p67) is a transmembrane receptor expressed on cells of myeloid lineage. It is usually considered myeloid-specific, but it can also be found on some lymphoid cells. CD33 can be stimulated by any molecule with sialic acid residues such as glycoproteins or glycolipids. Upon binding, the immunoreceptor tyrosine-based inhibition motif (ITIM) of CD33, present on the cytosolic portion of the protein, is phosphorylated and acts as a docking site for Src homology 2 (SH2) domain-containing proteins like SHP phosphatases. This results in a cascade that inhibits phagocytosis in the cell.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD117_BRIGHT</LocID>                               
		<Text>Proto-O c-KIT (CD117) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD117_BRIGHT_DESC</LocID>                   
		<Text>Proto-oncogene c-KIT, also known as tyrosine-protein kinase KIT, CD117 or mast/stem cell growth factor receptor, is a receptor tyrosine kinase protein that in humans is encoded by the KIT gene. KIT is an important cell surface marker used to identify certain types of hematopoietic (blood) progenitors in the bone marrow. To be specific, hematopoietic stem cells (HSC), multipotent progenitors (MPP), and common myeloid progenitors (CMP) express high levels of KIT. Common lymphoid progenitors (CLP) express low surface levels of KIT. Antibodies to KIT are widely used in immunohistochemistry to help distinguish particular types of tumour in histological tissue sections. It is used primarily in the diagnosis of GISTs, which are positive for KIT, but negative for markers such as desmin and S-100, which are positive in smooth muscle and neural tumors, which have a similar appearance.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD117_NEG</LocID>                               
		<Text>Proto-O c-KIT (CD117) Negative Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD117_NEG_DESC</LocID>                   
		<Text>Proto-oncogene c-KIT, also known as tyrosine-protein kinase KIT, CD117 or mast/stem cell growth factor receptor, is a receptor tyrosine kinase protein that in humans is encoded by the KIT gene. KIT is an important cell surface marker used to identify certain types of hematopoietic (blood) progenitors in the bone marrow. To be specific, hematopoietic stem cells (HSC), multipotent progenitors (MPP), and common myeloid progenitors (CMP) express high levels of KIT. Common lymphoid progenitors (CLP) express low surface levels of KIT. Antibodies to KIT are widely used in immunohistochemistry to help distinguish particular types of tumour in histological tissue sections. It is used primarily in the diagnosis of GISTs, which are positive for KIT, but negative for markers such as desmin and S-100, which are positive in smooth muscle and neural tumors, which have a similar appearance.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD38_BRIGHT</LocID>                               
		<Text>Cyclic ADP RH (CD38) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD38_BRIGHT_DESC</LocID>                   
		<Text>CD38, also known as cyclic ADP ribose hydrolase is a glycoprotein found on the surface of many immune cells, including CD4⁺, CD8⁺, B lymphocytes and natural killer cells. CD38 also functions in cell adhesion, signal transduction and calcium signaling. The loss of CD38 function is associated with impaired immune responses, metabolic disturbances, and behavioral modifications including social amnesia. The CD38 protein is a marker of cell activation. It has been connected to HIV infection, leukemias, myelomas, solid tumors, type II diabetes mellitus and bone metabolism, as well as some genetically determined conditions.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD38_DIM</LocID>                               
		<Text>Cyclic ADP RH (CD38) Dim Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD38_DIM_DESC</LocID>                   
		<Text>CD38, also known as cyclic ADP ribose hydrolase is a glycoprotein found on the surface of many immune cells, including CD4⁺, CD8⁺, B lymphocytes and natural killer cells. CD38 also functions in cell adhesion, signal transduction and calcium signaling. The loss of CD38 function is associated with impaired immune responses, metabolic disturbances, and behavioral modifications including social amnesia. The CD38 protein is a marker of cell activation. It has been connected to HIV infection, leukemias, myelomas, solid tumors, type II diabetes mellitus and bone metabolism, as well as some genetically determined conditions.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD43_BRIGHT</LocID>                               
		<Text>Leukosialin (CD43) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD43_BRIGHT_DESC</LocID>                   
		<Text>Leukosialin also known as sialophorin or CD43 (cluster of differentiation 43) is a transmembrane cell surface protein that in humans is encoded by the SPN (sialophorin) gene. Defects in the CD43 molecule are associated with the development of Wiskott-Aldrich syndrome. Using immunohistochemistry, CD43 can be demonstrated in the paracortical T-cells of healthy lymph nodes and tonsils; it is also positive in a range of lymphoid and myeloid tumours. Although it is present in over 90% of T-cell lymphomas, it is generally less effective at demonstrating this condition than is CD3 antigen. However, it may be useful as part of a panel to demonstrate B-cell lymphoblastic lymphoma, since the malignant cells in this condition are often CD43 positive, and may be difficult to stain with other antibodies.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD8_BRIGHT</LocID>                               
		<Text>CD8 Antigen Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD8_BRIGHT_DESC</LocID>                   
		<Text>CD8 (cluster of differentiation 8) is a transmembrane glycoprotein that serves as a co-receptor for the T cell receptor (TCR). Like the TCR, CD8 binds to a major histocompatibility complex (MHC) molecule, but is specific for the class I MHC protein. The CD8 co-receptor is predominantly expressed on the surface of cytotoxic T cells, but can also be found on natural killer cells, cortical thymocytes, and dendritic cells. The CD8 molecule is a marker for cytotoxic T cell population. It is expressed in T cell lymphoblastic lymphoma and hypo-pigmented mycosis fungoides.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD3_BRIGHT</LocID>                               
		<Text>CD3 Antigen Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD3_BRIGHT_DESC</LocID>                   
		<Text>In immunology, the CD3 (cluster of differentiation 3) T cell co-receptor helps to activate both the cytotoxic T cell (CD8+ naive T cells) and also T helper cells (CD4+ naive T cells). CD3 is initially expressed in the cytoplasm of pro-thymocytes, the stem cells from which T-cells arise in the thymus. The pro-thymocytes differentiate into common thymocytes, and then into medullary thymocytes, and it is at this latter stage that CD3 antigen begins to migrate to the cell membrane. The antigen is found bound to the membranes of all mature T-cells, and in virtually no other cell type, although it does appear to be present in small amounts in Purkinje cells. This high specificity, combined with the presence of CD3 at all stages of T-cell development, makes it a useful immunohistochemical marker for T-cells in tissue sections. The antigen remains present in almost all T-cell lymphomas and leukaemias, and can therefore be used to distinguish them from superficially similar B-cell and myeloid neoplasms.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD3_NEG</LocID>                               
		<Text>CD3 Antigen Negative Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD3_NEG_DESC</LocID>                   
		<Text>In immunology, the CD3 (cluster of differentiation 3) T cell co-receptor helps to activate both the cytotoxic T cell (CD8+ naive T cells) and also T helper cells (CD4+ naive T cells). CD3 is initially expressed in the cytoplasm of pro-thymocytes, the stem cells from which T-cells arise in the thymus. The pro-thymocytes differentiate into common thymocytes, and then into medullary thymocytes, and it is at this latter stage that CD3 antigen begins to migrate to the cell membrane. The antigen is found bound to the membranes of all mature T-cells, and in virtually no other cell type, although it does appear to be present in small amounts in Purkinje cells. This high specificity, combined with the presence of CD3 at all stages of T-cell development, makes it a useful immunohistochemical marker for T-cells in tissue sections. The antigen remains present in almost all T-cell lymphomas and leukaemias, and can therefore be used to distinguish them from superficially similar B-cell and myeloid neoplasms.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD16_BRIGHT</LocID>                               
		<Text>FcγRIII (CD16) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD16_BRIGHT_DESC</LocID>                   
		<Text>CD16, also known as FcγRIII, is a cluster of differentiation molecule found on the surface of natural killer cells, neutrophils, monocytes, and macrophages. CD16 has been identified as Fc receptors FcγRIIIa and FcγRIIIb, which participate in signal transduction. These receptors bind to the Fc portion of IgG antibodies, which then activates antibody-dependent cell-mediated cytotoxicity (ADCC) in human NK cells. CD16 is required for ADCC processes carried out by human monocytes. In humans, monocytes expressing CD16 have a variety of ADCC capabilities in the presence of specific antibodies, and can kill primary leukemic cells, cancer cell lines, and cells infected with hepatitis B virus. In addition, CD16 is able to mediate the direct killing of some virally infected and cancer cells without antibodies.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD56_BRIGHT</LocID>                               
		<Text>NC Adhesion Molecule (CD56) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD56_BRIGHT_DESC</LocID>                   
		<Text>Neural cell adhesion molecule (NCAM), also called CD56, is a homophilic binding glycoprotein expressed on the surface of neurons, glia and skeletal muscle. Although CD56 is often considered a marker of neural lineage commitment due to its discovery site, CD56 expression is also found in, among others, the hematopoietic system. Here, the expression of CD56 is most stringently associated with, but certainly not limited to, natural killer cells. In anatomic pathology, pathologists make use of CD56 immunohistochemistry to recognize certain tumors. Tumors that are CD56-positive are myeloma, myeloid leukemia, neuroendocrine tumors, Wilms' tumor, neuroblastoma, extranodal NK/T-cell lymphoma, nasal type, pancreatic acinar cell carcinoma, pheochromocytoma, paraganglioma, small cell lung carcinoma, and the Ewing's sarcoma family of tumors.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_HLADR_BRIGHT</LocID>                               
		<Text>HLA-DR Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_HLADR_BRIGHT_DESC</LocID>                   
		<Text>HLA-DR is an MHC class II cell surface receptor encoded by the human leukocyte antigen complex on chromosome 6 region 6p21.31. The complex of HLA-DR and peptide, generally between 9 and 30 amino acids in length, constitutes a ligand for the T-cell receptor.</Text>  
	</GameDBLocalizedString>
	
	<!-- ############### NORMAL STRINGS ############### -->
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_PANCYTOPENIA</LocID>                               
		<Text>Pancytopenia</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_PANCYTOPENIA_DESC</LocID>                   
		<Text>Pancytopenia is a condition that occurs when a person has low counts for all three types of blood cells: red blood cells, white blood cells, and platelets. Pancytopenia is usually due to a problem with the bone marrow that produces the blood cells. However, there can be several different underlying causes.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HAIRYCELL</LocID>                               
		<Text>Hairy Looking Cell</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HAIRYCELL_DESC</LocID>                   
		<Text>Hairy cells are abnormal white blood cells with hair-like projections of cytoplasm. They are a staple sign of Hairy cell leukemia.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SM_P_003</LocID>                               
		<Text>TRAP Enzyme Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SM_P_003_DESC</LocID>                   
		<Text>Tartrate-resistant acid phosphatase (TRAP or TRAPase), also called acid phosphatase 5, tartrate resistant (ACP5), is a glycosylated monomeric metalloprotein enzyme expressed in mammals. It has a molecular weight of approximately 35kDa, a basic isoelectric point (7.6–9.5), and optimal activity in acidic conditions.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_08</LocID>                               
		<Text>BRAF V600E Mutation Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_08_DESC</LocID>                   
		<Text>The B-Raf proto-oncogene (BRAF) encodes a cytoplasmic serine/threonine kinase with a key role in regulating the mitogen-activated protein kinase signal transduction pathway. An activating missense mutation in codon 600 of exon 15 (V600E) of BRAF gene has been identified in multiple neoplasms including melanoma, colorectal carcinoma, papillary thyroid carcinoma, hairy cell leukemia, and Langerhans cell histiocytosis.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_09</LocID>                               
		<Text>IGHV Hypermutation Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_09_DESC</LocID>                   
		<Text>Ig heavy chain V-III region VH26 is a protein that in humans is encoded by the IGHV@ gene. IGHV is the immunoglobulin heavy chain variable region genes; in B-cell neoplasms like chronic lymphocytic leukemia, mutations of IGHV are associated with better responses to some treatments and with prolonged survival. Approximately 80 to 90 percent of HCL patients have a hypermutation in immunoglobulin heavy chain variable gene. </Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC06_0_DETECTED</LocID>                               
		<Text>Hairy Cell Leukaemia (HCL) Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC06_0_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Hairy Cell Leukaemia.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC06_1_DETECTED</LocID>                               
		<Text>Hairy Cell Leukaemia Variant (HCL-V) Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC06_1_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Hairy Cell Leukaemia with evidence it is a rare variant.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_10</LocID>                               
		<Text>Deletion Chromosome 17p13 Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_10_DESC</LocID>                   
		<Text>Testing has detected Chromosome 17p13 is deleted from the patient's tested cells.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_NECROSIS</LocID>                               
		<Text>Necrosis</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_NECROSIS_DESC</LocID>                   
		<Text>Necrosis is a form of cell injury which results in the premature death of cells in living tissue by autolysis.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_LPT1</LocID>                               
		<Text>Large Primary Tumour Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_LPT1_DESC</LocID>                   
		<Text>Testing has detected a Large Primary Tumour within the patient, this can sometimes be sign that the cancer is in a more advanced state.</Text>  
	</GameDBLocalizedString>
	
	<!-- ### ### -->
	<!-- ######################################## Content for V0.13 Added Below ######################################## -->
	<!-- ### ### -->
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BREAST_LUMP</LocID>                               
		<Text>Breast Lump</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BREAST_LUMP_DESC</LocID>                   
		<Text>A breast lump is a localized swelling, protuberance, bulge, or bump in the breast that feels different from the breast tissue around it.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BREAST_DISCH</LocID>                               
		<Text>Breast Discharge</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BREAST_DISCH_DESC</LocID>                   
		<Text>Nipple discharge is the release of fluid from the nipple. It is a very common breast symptom and in most cases is part of the normal function of the breast rather than being caused by a problem.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SORE_NIPPLE</LocID>                               
		<Text>Sore Nipple</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SORE_NIPPLE_DESC</LocID>                   
		<Text>Nipple pain is pain that occurs in the breast tissue around the area of the nipple. Nipple pain can be associated with other symptoms and signs that may include breast pain, nipple discharge, breast lump or mass, itching, or skin changes. Breast cancer typically does not cause nipple pain or breast pain.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BREAST_SCHANGE</LocID>                               
		<Text>Breast Shape Changes</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BREAST_SCHANGE_DESC</LocID>                   
		<Text>The patient has experienced a change in the shape or size of their breasts.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BREAST_DIMP</LocID>                               
		<Text>Breast Dimpling</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BREAST_DIMP_DESC</LocID>                   
		<Text>Also known as peau d'orange, dimpling of the breast causes the skin to look like the pitting and uneven skin of an orange. Sometimes, the skin can also be red and inflamed.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BREAST_PAIN</LocID>                               
		<Text>Breast Pain</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BREAST_PAIN_DESC</LocID>                   
		<Text>Tightness, tenderness or sharp pain in one or both breasts that occurs commonly and usually doesn't mean anything is seriously wrong.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SUS_CALC</LocID>                               
		<Text>Suspicious Calcifications</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SUS_CALC_DESC</LocID>                   
		<Text>Breast calcifications are small calcium deposits that develop in a woman's breast tissue. They are very common and are usually benign (noncancerous). Breast calcifications are more common in women, but can also be found in men. In some instances, certain types of breast calcifications may suggest early breast cancer.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_IRR_BMASS</LocID>                               
		<Text>Irregular Breast Density</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_IRR_BMASS_DESC</LocID>                   
		<Text>A potential abnormality on a mammogram might be called a nodule, mass, lump, density, or distortion. A mass (lump) that has an irregular border or a starburst appearance (spiculated) might be cancerous.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CMA_CA153</LocID>                               
		<Text>Cancer Antigen 15-3 High Blood Levels</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CMA_CA153_DESC</LocID>                   
		<Text>Cancer antigen 15-3 (CA15-3) is a protein made by a variety of cells, particularly breast cancer cells. The protein moves into the blood, where it can be measured. CA15-3 levels are higher than normal in most women with breast cancer that has spread to other parts of the body (called metastatic breast cancer). Not all types of breast cancer will cause CA 15-3 levels to rise, as some types of cancer cells don’t over-produce the antigen.</Text>  
	</GameDBLocalizedString>
	
		<GameDBLocalizedString>      
		<LocID>SYM_CRP_CMA_CA2729</LocID>                               
		<Text>Cancer Antigen 27-29 High Blood Levels</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CMA_CA2729_DESC</LocID>                   
		<Text>Cancer Antigen 27-29 is one of several antigens that doctors use as tumor markers for breast cancer. These markers tend to increase whenever cancer is present. The CA 27.29 test is primarily used to monitor metastatic breast cancer and less commonly to detect recurrence in people previously treated for early-stage breast cancer.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BREC01_0_DETECTED</LocID>                               
		<Text>Ductal Carcinoma In Situ Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BREC01_0_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Ductal Carcinoma with evidence it is In Situ (in the original place and has not spread).</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_11</LocID>                               
		<Text>BRCA1 Faulty Gene Findings</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_11_DESC</LocID>                   
		<Text>BRCA1/2 is a human tumor suppressor gene (also known as a caretaker gene) and is responsible for repairing DNA. BRCA1 and BRCA2 are unrelated proteins, but both are normally expressed in the cells of breast and other tissue, where they help repair damaged DNA, or destroy cells if DNA cannot be repaired. Women who carry a fault in BRCA1 or BRCA2 have a high lifetime risk of breast cancer, estimated to be in the range of 30-60%, and a lifetime ovarian cancer risk of about 20%. They can benefit from measures for prevention and early detection of cancers. Men who carry a fault in BRCA1 or BRCA2 may be at some increased risk of prostate cancer and male breast cancer.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HRM_01</LocID>                               
		<Text>Estrogen Receptor Positive</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HRM_01_DESC</LocID>                   
		<Text>A cancer is called estrogen-receptor-positive (or ER+) if it has receptors for estrogen. This suggests that the cancer cells, like normal breast cells, may receive signals from estrogen that could promote their growth.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HRM_02</LocID>                               
		<Text>Progesterone Receptor Positive</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HRM_02_DESC</LocID>                   
		<Text>The cancer is progesterone-receptor-positive (PR+) if it has progesterone receptors. Again, this means that the cancer cells may receive signals from progesterone that could promote their growth.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD340_NEG</LocID>                               
		<Text>HER2/neu (CD340) Negative Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD340_NEG_DESC</LocID>                   
		<Text>Receptor tyrosine-protein kinase erbB-2, also known as CD340, proto-oncogene Neu, Erbb2, or ERBB2, is a protein that in humans is encoded by the ERBB2 gene. ERBB is abbreviated from erythroblastic oncogene B, a gene isolated from avian genome. It is also frequently called HER2 or HER2/neu. HER2 is a member of the human epidermal growth factor receptor (HER/EGFR/ERBB) family. Amplification or over-expression of this oncogene has been shown to play an important role in the development and progression of certain aggressive types of breast cancer. In recent years the protein has become an important biomarker and target of therapy for approximately 30% of breast cancer patients.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD340_POS</LocID>                               
		<Text>HER2/neu (CD340) Positive Mutation</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD340_POS_DESC</LocID>                   
		<Text>Receptor tyrosine-protein kinase erbB-2, also known as CD340, proto-oncogene Neu, Erbb2, or ERBB2, is a protein that in humans is encoded by the ERBB2 gene. ERBB is abbreviated from erythroblastic oncogene B, a gene isolated from avian genome. It is also frequently called HER2 or HER2/neu. HER2 is a member of the human epidermal growth factor receptor (HER/EGFR/ERBB) family. Amplification or over-expression of this oncogene has been shown to play an important role in the development and progression of certain aggressive types of breast cancer. In recent years the protein has become an important biomarker and target of therapy for approximately 30% of breast cancer patients.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SPEC_MARG</LocID>                               
		<Text>Spiculated Margins</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SPEC_MARG_DESC</LocID>                   
		<Text>Spiculated margins are a true diagnostic feature of malignancy. Strands of tissue are seen radiating out from an ill-defined mass, producing a stellate appearance.</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BREC01_1_DETECTED</LocID>                               
		<Text>Invasive Ductal Carcinoma (IDC) Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BREC01_1_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Ductal Carcinoma with evidence it is Invasive, having invaded the surrounding tissues.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD44v6_BRIGHT</LocID>                               
		<Text>CD44v6 Antigen Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD44v6_BRIGHT_DESC</LocID>                   
		<Text>CD44v6 is an isoform of the CD44 family of transmembrane glycoproteins. High CD44v6 expression in epithelial cancer correlates with tumor growth, invasion, metastasis, and recurrence. CD44v6 is a co-receptor of the receptor tyrosine kinases c-Met, RON and VEGFR-2.</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_12</LocID>                               
		<Text>GATA3 Mutation Findings</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_12_DESC</LocID>                   
		<Text>GATA3 is a transcription factor that in humans is encoded by the GATA3 gene. The GATA3 transcription factor is critical for the embryonic development of various tissues as well as for inflammatory and humoral immune responses and the proper functioning of the endothelium of blood vessels. Immuocytochemical analysis of GATA3 protein in breast cells is a valuable marker for diagnosing primary breast cancer, being tested as positive in up to 94% of cases.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BREC01_2_DETECTED</LocID>                               
		<Text>Metastatic Breast Cancer Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BREC01_2_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Breast Cancer with evidence it is Metastatic.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_SL_HEMOPTYSIS2</LocID>                               
		<Text>Severe Hemoptysis</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_SL_HEMOPTYSIS2_DESC</LocID>                   
		<Text>Hemoptysis is the coughing up of blood or blood-stained mucus from the bronchi, larynx, trachea, or lungs. In other words, it is the airway bleeding. This can occur with lung cancer, infections such as tuberculosis, bronchitis, or pneumonia, and certain cardiovascular conditions.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_INC_INTRAPRE</LocID>                               
		<Text>Increased Intracranial Pressure</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_INC_INTRAPRE_DESC</LocID>                   
		<Text>Increased intracranial pressure (ICP) is a rise in pressure around your brain. It may be due to an increase in the amount of fluid surrounding your brain. For example, there may be an increased amount of the cerebrospinal fluid that naturally cushions your brain or an increase in blood in the brain due to an injury or a ruptured tumor.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BRAIN_ABW</LocID>                               
		<Text>Abnormal Brain Wave Patterns</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BRAIN_ABW_DESC</LocID>                   
		<Text>EEG has detected abnormal brain wave patterns. Spikes, sharp waves, or spike-wave complexes occurring with consistent localization are observed sometimes early in the course of brain tumors. However, they are more common either as early findings of slowly growing neoplasms associated with seizures or later after focal slowing has developed.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_LPT2</LocID>                               
		<Text>Abnormal Mass Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_LPT2_DESC</LocID>                   
		<Text>Testing has detected an abnormal mass within the patient, further testing is required to identify malignancy, type or progression.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BRAC01_0_DETECTED</LocID>                               
		<Text>Pilocytic Astrocytoma Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BRAC01_0_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Pilocytic Astrocytoma within the patient.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_13</LocID>                               
		<Text>Neurofibromatosis Type I (NF-1) Findings</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_13_DESC</LocID>                   
		<Text>Neurofibromatosis type I (NF-1) is a complex multi-system human disorder caused by the mutation of a gene on chromosome 17 that is responsible for production of a protein called neurofibromin which is needed for normal function in many human cell types. Approximately 10% of patients with neurofibromatosis I (NFI) patients will have central nervous system (CNS) tumors. The most common of these are hypothalamic-optic gliomas, followed by brainstem and cerebellar pilocytic astrocytomas.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_EGB</LocID>                               
		<Text>Eosinophilic Granular Bodies</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_EGB_DESC</LocID>                   
		<Text>The frequent presence of eosinophilic granular bodies is often a useful clue in deterring a higher grade neoplasm toward a lower grade tumor, such as a pleomorphic xanthoastrocytoma (PXA) or a pilocytic astrocytoma.</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_SL_ABSCESS</LocID>                               
		<Text>Abscess</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_FND</LocID>                   
		<Text>Focal Neurologic Deficit</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_CRP_FND_DESC</LocID>                               
		<Text>A focal neurologic deficit is a problem with nerve, spinal cord, or brain function. It affects a specific location, such as the left side of the face, right arm, or even a small area such as the tongue. Speech, vision, and hearing problems are also considered focal neurological deficits.</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CMD</LocID>                   
		<Text>Calcified Mineral Deposits</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CMD_DESC</LocID>                               
		<Text>Brain stones or cerebral calculi are defined as large solid intracranial calcifications. While considered by many to be benign, these calcium phosphate deposits or "brain stones" can become large and are associated with neurological symptoms that range from seizures to parkinsonian symptoms. Dystrophic calcifications are most commonly seen in areas of brain injury such as trauma, surgery, stroke and radiation treatment.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_DYSPHASIA</LocID>                   
		<Text>Dysphasia</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_14</LocID>                   
		<Text>Li-Fraumeni Syndrome (LFS)</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_14_DESC</LocID>                               
		<Text>Li-Fraumeni syndrome (LFS) is an inherited familial predisposition to a wide range of certain, often rare, cancers. This is due to a change (mutation) in a tumor suppressor gene known as TP53.</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_CRP_DYSPHASIA_DESC</LocID>                               
		<Text>Dysphasia is a language disorder marked by deficiency in the generation of speech, and sometimes also in its comprehension, due to brain disease or damage.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_MCRO_CYSTS</LocID>                   
		<Text>Microcysts</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_CRP_MCRO_CYSTS_DESC</LocID>                               
		<Text>A microcyst is simply a very small cyst. Cysts are an abnormal, usually noncancerous growth filled with liquid or a semisolid substance, sometimes causing pain.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BRAC01_1_DETECTED</LocID>                               
		<Text>Diffuse Astrocytoma Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BRAC01_1_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Diffuse Astrocytoma within the patient.</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_KI67_LLI</LocID>                               
		<Text>Antigen KI-67 Low Labeling Index</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_KI67_LLI_DESC</LocID>                   
		<Text>Antigen KI-67 also known as Ki-67 or MKI67 is a protein that in humans is encoded by the MKI67 gene (antigen identified by monoclonal antibody Ki-67). Ki-67 is an excellent marker to determine the growth fraction of a given cell population. The fraction of Ki-67-positive tumor cells (the Ki-67 labeling index) is often correlated with the clinical course of cancer.</Text>  
	</GameDBLocalizedString>

	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_KI67_BLI</LocID>                               
		<Text>Antigen KI-67 Brisk Labeling Index</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BRAC01_2_DETECTED</LocID>                               
		<Text>Anaplastic Astrocytoma Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BRAC01_2_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Anaplastic Astrocytoma within the patient.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_15</LocID>                               
		<Text>Loss of Heterozygosity</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_15_DESC</LocID>                   
		<Text>Loss of heterozygosity on chromosome arm 10q is the most frequent gene alteration for both primary and secondary glioblastomas; it occurs in 60-90% of cases. This mutation appears to be specific for glioblastoma multiforme and is found rarely in other tumor grades. This mutation is associated with poor survival. LOH at 10q plus 1 or 2 of the additional gene mutations appear to be frequent alterations and are most likely major players in the development of glioblastomas.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_16</LocID>                               
		<Text>Overexpression of PDGFR</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_16_DESC</LocID>                   
		<Text>Platelet-derived growth factor (PDGF) is one among numerous growth factors that regulate cell growth and division. In particular, PDGF plays a significant role in blood vessel formation, the growth of blood vessels from already-existing blood vessel tissue, mitogenesis, i.e. proliferation, of mesenchymal cells. In Oncology, the PDGF gene acts as a major mitogen for glial cells by binding to the PDGF receptor (PDGFR). Amplification or overexpression of PDGFR is typical in the pathway leading to secondary glioblastomas.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_017</LocID>                               
		<Text>IDH1/IDH2 Mutation Negative</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_DYSPAREUNIA</LocID>                   
		<Text>Dyspareunia (Female)</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_DYSPAREUNIA_DESC</LocID>                               
		<Text>Painful intercourse can occur for reasons that range from structural problems to psychological concerns. Many women have painful intercourse at some point in their lives. The medical term for painful intercourse is dyspareunia, defined as persistent or recurrent genital pain that occurs just before, during or after intercourse.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CMA_CA125</LocID>                   
		<Text>Cancer Antigen 125 High Blood Levels</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CMA_CA125_DESC</LocID>                               
		<Text>CA-125 also known as mucin 16 or MUC16 is a protein that in humans is encoded by the MUC16 gene. MUC16 is a member of the mucin family glycoproteins. A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in your blood. A CA 125 test may be used to monitor certain cancers during and after treatment. In some cases, a CA 125 test may be used to look for early signs of ovarian cancer in people with a very high risk of the disease. The amount of CA-125 is higher with ovarian cancer. In premenopausal women, many other illnesses or diseases besides cancer can cause higher levels of CA-125.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_OVAC1_0F_DETECTED</LocID>                               
		<Text>High-Grade Serous Carcinoma (HGSC) Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_OVAC1_0F_DETECTED_DESC</LocID>                   
		<Text>Testing has detected High-Grade Serous Carcinoma within the patient.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_EARLY_SAT</LocID>                               
		<Text>Early Satiety</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_EARLY_SAT_DESC</LocID>                   
		<Text>Early satiety is the inability to eat a full meal or feeling full after only a small amount of food.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_PMPB</LocID>                               
		<Text>Postmenopausal Bleeding</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_PMPB_DESC</LocID>                   
		<Text>Postmenopausal bleeding (PMB) is defined as bleeding that occurs after 1 year of amenorrhea in a woman who is not receiving hormone therapy (HT). Women on continuous progesterone and oestrogen hormone therapy can expect to have irregular vaginal bleeding, especially for the first 6 months. There can be several causes of postmenopausal bleeding. The most common causes are: inflammation and thinning of the vaginal lining (atrophic vaginitis) or womb lining (endometrial atrophy) – caused by lower oestrogen levels.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_IRR_MNS</LocID>                               
		<Text>Irregular Menstruation</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_IRR_MNS_DESC</LocID>                   
		<Text>Missed, delayed or erratic periods or abnormal bleeding patterns. Irregular menstruation can have causes that aren't due to underlying disease. Examples include family history of irregular menstruation, menopause or menarche, physical stress, psychological stress, smoking or medication side effects.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_APM</LocID>                               
		<Text>Abnormal Pelvic Mass Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_APM_DESC</LocID>                   
		<Text>A pelvic mass is an enlargement or swelling in the pelvic region. Most pelvic masses are discovered during routine gynecologic or physical examinations. Pelvic masses may originate from either the gynecologic organs, such as the cervix, uterus, uterine adnexa, or from other pelvic organs, such as the intestines, bladder, ureters, and renal organs. There are many gynecologic problems that can result in a pelvic mass. Additionally, there are other diseases that may also result in a pelvic mass. Most are benign conditions, such as an Ovarian Cyst, while others can be related to gynecologic cancer.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_OVAR_CYST</LocID>                               
		<Text>Abnormal Pelvic Mass Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_OVAR_CYST_DESC</LocID>                   
		<Text>Ovarian cysts are fluid-filled sacs or pockets in an ovary or on its surface. Most ovarian cysts don't cause symptoms. In some cases, menstrual irregularities, pain during intercourse or irregular bowel movements can occur. Most ovarian cysts are harmless and often clear up on their own without treatment.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_OVAC1_1F_DETECTED</LocID>                               
		<Text>Low-Grade Serous Carcinoma (LGSC) Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_OVAC1_1F_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Low-Grade Serous Carcinoma within the patient.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SM_P_004</LocID>                               
		<Text>Micropapillary Invasion Pattern</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SM_P_004_DESC</LocID>                   
		<Text>A micropapillary pattern is defined as a pattern showing micropapillary structures without a fibrovascular core. It is well known that the presence of a micropapillary pattern leads to a poorer prognosis in ovary, breast and bladder cancer.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SM_P_005</LocID>                               
		<Text>Psammoma Body</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SM_P_005_DESC</LocID>                   
		<Text>Psammoma bodies are round microscopic calcific collections. Psammoma bodies are a common finding in well-differentiated serous carcinoma and they may be found in association with malignant glandular cells detected with cervicovaginal cytology.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_18</LocID>                               
		<Text>BRAF V599E Mutation Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_18_DESC</LocID>                   
		<Text>The B-Raf proto-oncogene (BRAF) encodes a cytoplasmic serine/threonine kinase with a key role in regulating the mitogen-activated protein kinase signal transduction pathway. Mutations in the BRAF-gene are found in benign and malignant melanocytic lesions, >90% being a V599E mutation. This mutation results in constitutively active kinase function and increased colony formation in vitro.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ASCITES</LocID>                               
		<Text>Ascites</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ASCITES_DESC</LocID>                   
		<Text>Abdominal swelling caused by accumulation of fluid, most often related to liver disease.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_PLEURAL_EFFUSION</LocID>                               
		<Text>Pleural Effusion</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_PLEURAL_EFFUSION_DESC</LocID>                   
		<Text>Pleural effusion, sometimes referred to as “water on the lungs,” is the build-up of excess fluid between the layers of the pleura outside the lungs. The pleura are thin membranes that line the lungs and the inside of the chest cavity and act to lubricate and facilitate breathing.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD146_BRIGHT</LocID>                               
		<Text>MCAM (CD146) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD146_BRIGHT_DESC</LocID>                   
		<Text>Melanoma cell adhesion molecule (MCAM) is a cell adhesion molecule that is abnormally expressed in a variety of tumours and is closely associated with tumour metastasis.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CK7_BRIGHT</LocID>                               
		<Text>Keratin 7 (CK7) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CK7_BRIGHT_DESC</LocID>                   
		<Text>Keratin, type II cytoskeletal 7 also known as cytokeratin-7 (CK-7) or keratin-7 (K7) or sarcolectin (SCL) is a protein that in humans is encoded by the KRT7 gene. Keratin-7 is found in simple glandular epithelia, and in transitional epithelium. Epithelial cells of the lung and breast both contain keratin-7, but some other glandular epithelia, such as those of the colon and prostate, do not. Because the keratin-7 antigen is found in both healthy and neoplastic cells, antibodies to CK7 can be used in immunohistochemistry to distinguish ovarian and transitional cell carcinomas from colonic and prostate cancers, respectively. It is commonly used together with CK20 when making such diagnoses.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CK7_NEG</LocID>                               
		<Text>Keratin 7 (CK7) Negative Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CK7_NEG_DESC</LocID>                   
		<Text>Keratin, type II cytoskeletal 7 also known as cytokeratin-7 (CK-7) or keratin-7 (K7) or sarcolectin (SCL) is a protein that in humans is encoded by the KRT7 gene. Keratin-7 is found in simple glandular epithelia, and in transitional epithelium. Epithelial cells of the lung and breast both contain keratin-7, but some other glandular epithelia, such as those of the colon and prostate, do not. Because the keratin-7 antigen is found in both healthy and neoplastic cells, antibodies to CK7 can be used in immunohistochemistry to distinguish ovarian and transitional cell carcinomas from colonic and prostate cancers, respectively. It is commonly used together with CK20 when making such diagnoses.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CK20_BRIGHT</LocID>                               
		<Text>Keratin 20 (CK20) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CK20_BRIGHT_DESC</LocID>                   
		<Text>Keratin 20, often abbreviated CK20, is a protein that in humans is encoded by the KRT20 gene. In immunohistochemistry, antibodies to CK20 can be used to identify a range of adenocarcinoma arising from epithelia that normally contain the CK20 protein. For example, the protein is commonly found in colorectal cancer, transitional cell carcinomas and in Merkel cell carcinoma, but is absent in lung cancer, prostate cancer, and non-mucinous ovarian cancer. It is often used in combination with antibodies to CK7 to distinguish different types of glandular tumour.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CK20_NEG</LocID>                               
		<Text>Keratin 20 (CK20) Negative Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CK20_NEG_DESC</LocID>                   
		<Text>Keratin 20, often abbreviated CK20, is a protein that in humans is encoded by the KRT20 gene. In immunohistochemistry, antibodies to CK20 can be used to identify a range of adenocarcinoma arising from epithelia that normally contain the CK20 protein. For example, the protein is commonly found in colorectal cancer, transitional cell carcinomas and in Merkel cell carcinoma, but is absent in lung cancer, prostate cancer, and non-mucinous ovarian cancer. It is often used in combination with antibodies to CK7 to distinguish different types of glandular tumour.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_17</LocID>                               
		<Text>IDH1/IDH2 Negative Findings</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_17_DESC</LocID>                   
		<Text>Isocitrate dehydrogenase (IDH) is a key enzyme involved in the conversion of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid (TCA) cycle. IDH mutation produces a neomorphic enzyme, which can lead to the abnormal accumulation of R-2-HG and promotes leukemogenesis. IDH mutation occurs in 20% of acute myeloid leukemia (AML) patients, mainly including IDH1 R132, IDH2 R140, and IDH2 R172.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BRAC01_3_DETECTED</LocID>                               
		<Text>Glioblastoma Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BRAC01_3_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Glioblastoma within the patient.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_PSA_BL_DETECTED</LocID>                               
		<Text>Prostate Specific Antigen High Levels</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_PSA_BL_DETECTED_DESC</LocID>                   
		<Text>Prostate specific antigen (PSA) is a glycoprotein produced solely by the prostate. Its function is to liquefy semen. Small amounts leak into the bloodstream, where it can be measured. Prostate specific antigen is tissue-specific but not cancer-specific. Elevated levels can occur in men with benign prostatic hypertrophy (BPH), prostatitis, urinary tract infection or prostatic infarction.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_DYSORGASMIA</LocID>                   
		<Text>Dysorgasmia</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_DYSORGASMIA_DESC</LocID>                               
		<Text>Dysorgasmia is defined as a painful orgasm, but without any prior pain during sexual intercourse. The pain is often a cramping sensation in the pelvis, buttock or abdomen.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_APM1</LocID>                               
		<Text>Abnormal Prostate Findings</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_APM1_DESC</LocID>                   
		<Text>Testing has found abnormalities with the patient's prostate.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_PROC1_0M_DETECTED</LocID>                               
		<Text>Prostate Cancer (Stage 1) Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_PROC1_0M_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Prostate Cancer (Stage 1) within the patient.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_PROC1_1M_DETECTED</LocID>                               
		<Text>Prostate Cancer (Stage 2) Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_PROC1_1M_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Prostate Cancer (Stage 2) within the patient.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_PROC1_2M_DETECTED</LocID>                               
		<Text>Prostate Cancer (Stage 3) Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_PROC1_2M_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Prostate Cancer (Stage 3) within the patient.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_PROC1_3M_DETECTED</LocID>                               
		<Text>Prostate Cancer (Stage 4) Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_PROC1_3M_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Prostate Cancer (Stage 4) within the patient.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_DIFF_URINE</LocID>                               
		<Text>Urinary Retention</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_DIFF_URINE_DESC</LocID>                   
		<Text>Difficulty urinating and completely emptying the bladder. Urinary retention can have causes that aren't due to underlying disease. Examples include holding in urine intentionally or medication side effects.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_NIGHT_URGE</LocID>                               
		<Text>Frequent Urination at Night</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_NIGHT_URGE_DESC</LocID>                   
		<Text>A frequent need to get up and go to the bathroom to urinate at night is called nocturia. It differs from enuresis, or bedwetting, in which the person does not arouse from sleep, but the bladder empties anyway. Nocturia is a common cause of sleep loss, especially among older adults.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_UAS_PCA3</LocID>                               
		<Text>Prostate Cancer Antigen 3 High Levels</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_UAS_PCA3_DESC</LocID>                   
		<Text>Prostate cancer antigen 3 (PCA3) is highly expressed in prostatic tumors. Testing has returned high urine levels of PCA3.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_UAS_PCA3</LocID>                               
		<Text>Prostate Cancer Antigen 3 High Levels</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_UAS_PCA3_DESC</LocID>                   
		<Text>Prostate cancer antigen 3 (PCA3) is highly expressed in prostatic tumors. Testing has returned high urine levels of PCA3.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ED</LocID>                               
		<Text>Erectile Dysfunction</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ED_DESC</LocID>                   
		<Text>Erectile dysfunction (ED) is the inability to get or keep an erection firm enough to have sexual intercourse. It's sometimes referred to as impotence, although this term is now used less often. Occasional ED isn't uncommon. Many men experience it during times of stress. Erectile dysfunction following radical prostatectomy for clinically localized prostate cancer is a known potential complication of the surgery.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HEMATOSPERMIA</LocID>                               
		<Text>Hematospermia</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HEMATOSPERMIA_DESC</LocID>                   
		<Text>Hematospermia is defined as blood in the semen. While often perceived as having little significance, blood in the ejaculate can cause great concern to the men who experience it. The condition is common, with many episodes going unnoticed; therefore, the prevalence of hematospermia remains unknown.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HYPERCALCEMIA</LocID>                               
		<Text>Hypercalcemia</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_HYPERCALCEMIA_DESC</LocID>                   
		<Text>Hypercalcemia is a condition in which the calcium level in your blood is above normal. Hypercalcaemia is most often caused by overactivity in the four tiny glands in the neck (parathyroid glands) or from cancer. Extra calcium in the blood affects many bodily systems.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SEVERE_HYPERCALCEMIA</LocID>                               
		<Text>Severe Hypercalcemia</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SEVERE_HYPERCALCEMIA_DESC</LocID>                   
		<Text>Severe hypercalcemia is a medical emergency requiring urgent treatment. Hypercalcemia is a condition in which the calcium level in your blood is above normal. Rarely, severe hypercalcemia can interfere with your heart function, causing palpitations and fainting, indications of cardiac arrhythmia, and other heart problems.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_OVAC1_2F_DETECTED</LocID>                               
		<Text>Metastatic Ovarian Cancer Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_OVAC1_2F_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Metastatic Ovarian Cancer within the patient.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD13_NEG</LocID>                               
		<Text>Aminopeptidase N (CD13) Negative Expression</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD30_BRIGHT</LocID>                   
		<Text>CD30 Antigen Bright Expression</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD30_BRIGHT_DESC</LocID>                               
		<Text>CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family and tumor marker. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. CD30 is associated with anaplastic large cell lymphoma. It is expressed in embryonal carcinoma but not in seminoma and is thus a useful marker in distinguishing between these germ cell tumors. CD30 and CD15 are also expressed on Reed-Sternberg cells typical for Hodgkin's lymphoma.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC07_0_DETECTED</LocID>                               
		<Text>Diffuse Large B-Cell (NOS) Lymphoma Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC07_0_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Diffuse Large B-Cell (NOS) Lymphoma.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD45_BRIGHT</LocID>                               
		<Text>PTPRC (CD45) Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_CD45_BRIGHT_DESC</LocID>                   
		<Text>Protein tyrosine phosphatase, receptor type, C also known as PTPRC is an enzyme that, in humans, is encoded by the PTPRC gene. PTPRC is also known as CD45 antigen (CD stands for cluster of differentiation), which was originally called leukocyte common antigen (LCA). CD45 is a pan-leukocyte protein with tyrosine phosphatase activity involved in the regulation of signal transduction in hematopoiesis. CD45 does not colocalize with lipid rafts on murine and human non-transformed hematopoietic cells, but CD45 positioning within lipid rafts is modified during their oncogenic transformation to acute myeloid leukemia.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_19</LocID>                               
		<Text>IGH-BCL2 Translocation</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_19_DESC</LocID>                   
		<Text>The hallmark of Follicular lymphoma (FL) is the aberrant translocation t(14; 18)(q32; q21) involving the IgH locus on chromosome 14 and BCL2 gene on chromosome 18.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_20</LocID>                               
		<Text>BCL6 (3q27) Hypermutation</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_20_DESC</LocID>                   
		<Text>B-cell lymphoma 6 protein is a protein that in humans is encoded by the BCL6 gene. Like BCL2, BCL3, BCL5, BCL7A, BCL9 and BCL10, it has clinical significance in lymphoma. The protein encoded by this gene is an evolutionarily conserved zinc finger transcription factor and contains an N-terminal POZ/BTB domain. This protein acts as a sequence-specific repressor of transcription and has been shown to modulate the STAT-dependent Interleukin 4 (IL-4) responses of B cells. This protein can interact with several corepressor complexes to inhibit transcription. This gene is found to be frequently translocated and hypermutated in diffuse large B cell lymphoma (DLBCL).</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC08_0_DETECTED</LocID>                               
		<Text>Follicular Lymphoma Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC08_0_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Follicular Lymphoma.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_BLC2_BRIGHT</LocID>                               
		<Text>BCL2 Bright Expression</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CM_BLC2_BRIGHT_DESC</LocID>                   
		<Text>Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis. Antibodies to Bcl-2 can be used with immunohistochemistry to identify cells containing the antigen. In healthy tissue, these antibodies react with B-cells in the mantle zone, as well as some T-cells. However, positive cells increase considerably in follicular lymphoma, as well as many other forms of cancer. In some cases, the presence or absence of Bcl-2 staining in biopsies may be significant for the patient's prognosis or likelihood of relapse.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BL_DGP</LocID>                               
		<Text>Diffuse Growth Pattern</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_BL_DGP_DESC</LocID>                   
		<Text>Vaguely nodular and/or diffuse cellular growth pattern.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC4_0_DETECTED</LocID>                               
		<Text>Merkel Cell Carcinoma Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC4_0_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Merkel Cell Carcinoma with evidence it is only local.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ABNORMAL_NODULE</LocID>                               
		<Text>Abnormally Coloured Nodule</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_ABNORMAL_NODULE_DESC</LocID>                   
		<Text>The patient has a nodule (a lump) on the skin that has a strange red/violet colour.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_MCP_VIR</LocID>                               
		<Text>Merkel Cell Polyomavirus Findings</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_MCP_VIR_DESC</LocID>                   
		<Text>Merkel cell polyomavirus (MCV or MCPyV) was first described in January 2008 in Pittsburgh, Pennsylvania. It was the first example of a human viral pathogen discovered using unbiased metagenomic next-generation sequencing with a technique called digital transcriptome subtraction. MCV is one of seven currently known human oncoviruses. Detection of the virus is still at a research phase and is generally not available as a clinical test. Detection of viral DNA is performed by PCR or FISH.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_MCP_VIR_EL</LocID>                               
		<Text>Electron Microscope MCV Findings</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_MCP_VIR_EL_DESC</LocID>                   
		<Text>Transmission electron microscopy of MCV VLP at ×50,000 magnification shows characteristic polyomaviral icosahedral capsid structures. This evidence points towards Merkel cell polyomavirus or MCV, which is one of seven currently known human oncoviruses. </Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC4_1_DETECTED</LocID>                               
		<Text>Merkel Cell Carcinoma Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_SC4_1_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Merkel Cell Carcinoma with evidence it is metastatic.</Text>  
	</GameDBLocalizedString>
	
	<!-- ### ### -->
	<!-- ######################################## Content for V0.13.1a Added Below ######################################## -->
	<!-- ### ### -->
	
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC09_0_DETECTED</LocID>                               
		<Text>Mantle Cell Lymphoma Detected</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_ONCO_BLC09_0_DETECTED_DESC</LocID>                   
		<Text>Testing has detected Mantle Cell Lymphoma.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SM_P_006</LocID>                               
		<Text>Cyclin D1 Overproduction</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_SM_P_006_DESC</LocID>                   
		<Text>Cyclin D1 is a protein that regulates entry of the cell into cell cycle. It drives the transition between G0 and G1 phase. In normal tissues, basal epithelial cells, endothelial cells, and stromal cells are often cyclin D1 positive, as these cells are going through the cell cycle. As a result of a translocation involving the cyclin D1 gene and IgH, t(11;14), the vast majority of mantle cell lymphomas overexpress cyclin D1. This is a useful feature in the classification of low-grade B-cell lymphomas.</Text>  
	</GameDBLocalizedString>
	
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_21</LocID>                               
		<Text>IGH/CCND1 Translocation Findings</Text>  
	</GameDBLocalizedString>
            
	<GameDBLocalizedString>      
		<LocID>SYM_CRP_CDF_T_21_DESC</LocID>                   
		<Text>IGH gene rearrangements are considered to be one of the classical cytogenetic gene aberrations associated with numerous cancers. The molecular hallmark of MCL, t(11;14)(q13;q32) (IGH/CCND1), results in deregulation and overexpression of the G1-phase cell cycle gene, CCND1 (encoding cyclin D1), mediated by enhancer elements found throughout the IGH locus.</Text>  
	</GameDBLocalizedString>
	
	<!-- ### ### -->
	<!-- ######################################## Content for V0.13.2a Added Below ######################################## -->
	<!-- ### ### -->
	
	</LocalizedStrings>
	</GameDBStringTable>
</Database>